摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(4-chlorophenyl)-5-(2-diethylaminoethyl)-1-methyl-4-phenyl-5,6-dihydro-3H-pyrimidin-2-one

中文名称
——
中文别名
——
英文名称
6-(4-chlorophenyl)-5-(2-diethylaminoethyl)-1-methyl-4-phenyl-5,6-dihydro-3H-pyrimidin-2-one
英文别名
4-(4-Chlorophenyl)-5-[2-(diethylamino)ethyl]-3-methyl-6-phenyl-1,4-dihydropyrimidin-2-one
6-(4-chlorophenyl)-5-(2-diethylaminoethyl)-1-methyl-4-phenyl-5,6-dihydro-3H-pyrimidin-2-one化学式
CAS
——
化学式
C23H28ClN3O
mdl
——
分子量
397.948
InChiKey
LXEPYDWSLLSSIS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    28
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    35.6
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    N-甲基脲 、 2-[1-(4-Chloro-phenyl)-meth-(E)-ylidene]-4-diethylamino-1-phenyl-butan-1-one 在 sodium ethanolate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 12.0h, 以48%的产率得到6-(4-chlorophenyl)-5-(2-diethylaminoethyl)-1-methyl-4-phenyl-5,6-dihydro-3H-pyrimidin-2-one
    参考文献:
    名称:
    A Combinatorial Scaffold Approach Based upon a Multicomponent Reaction
    摘要:
    A combinatorial scaffolding procedure for the synthesis and spatial arrangement of tripartite structures was developed.
    DOI:
    10.1021/ol0343313
点击查看最新优质反应信息

文献信息

  • 2-Aminoethyl Substituted Pyrimidin-2-Ones Cyclopropanes, Pyrazolines, Pyrimidines and Benzothiazepines and Their Uses as Urotensin II and Somatostatin 5 Receptor Ligands
    申请人:Olsson Roger
    公开号:US20100029612A1
    公开(公告)日:2010-02-04
    The present invention provides a combinatorial approach to a library of novel compounds having four diversity points. The compounds provide for the mapping of urotensin II and somatostatin 5 receptors by differential binding of said receptors. The present invention further relates to a method of treating diseases for which modulation of the urotensin II receptor produces a physiologically beneficial response in said disease, such as those associated with CNS function and cardiovascular diseases. The present invention further relates to pharmaceutical compositions comprising these agents for the treatment of these diseases adapted to modulate the urotensin II receptor.
查看更多